Bisha Ding
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in ⓘ
-
- MicroRNA in disease regulation 20
- Cancer-related molecular mechanisms research 17
-
- Antimicrobial Peptides and Activities 3
- Co-authors
- Weiyang Lou (24 shared papers)Weimin Fan (17 shared papers)Liang Xu (12 shared papers)Weimin Fan (7 shared papers)Weiyang Lou (9 shared papers)Peifen Fu (4 shared papers)Jin‐Xing Liu (8 shared papers)Guansheng Zhong (6 shared papers)
- Journals
- Aging (5 papers)Frontiers in Cell and Developmental Biology (3 papers)Bioscience Reports (2 papers)Cell Death and Disease (2 papers)Journal of Translational Medicine (2 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Bisha Ding
34 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 93
- Cancer Research 1.1k
- Molecular Biology 1.2k
- Microbiology 75
- Pulmonary and Respiratory Medicine 207
- Molecular Medicine 23
Countries citing papers authored by Bisha Ding
This map shows the geographic impact of Bisha Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bisha Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bisha Ding more than expected).
Fields of papers citing papers by Bisha Ding
This network shows the impact of papers produced by Bisha Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bisha Ding. The network helps show where Bisha Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Bisha Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 150 | |
| 2 | 2020 | 114 | |
| 3 | 2017 | 96 | |
| 4 | 2018 | 81 | |
| 5 | 2018 | 78 | |
| 6 | 2019 | 77 | |
| 7 | MicroRNA regulation of liver cancer stem cells. | 2018 | 73 |
| 8 | 2018 | 70 | |
| 9 | 2020 | 64 | |
| 10 | 2019 | 61 | |
| 11 | 2020 | 60 | |
| 12 | 2018 | 51 | |
| 13 | 2019 | 51 | |
| 14 | 2019 | 46 | |
| 15 | 2019 | 46 | |
| 16 | 2019 | 45 | |
| 17 | 2020 | 44 | |
| 18 | 2019 | 44 | |
| 19 | 2020 | 40 | |
| 20 | 2020 | 36 |
About Bisha Ding
Bisha Ding is a scholar working on Cancer Research, Microbiology, Molecular Biology, Endocrinology and Hepatology, having authored 34 papers that have together received 1.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (20 papers), Cancer-related molecular mechanisms research (17 papers), Circular RNAs in diseases (13 papers), RNA modifications and cancer (12 papers), Ferroptosis and cancer prognosis (4 papers), Antimicrobial agents and applications (3 papers), Antimicrobial Peptides and Activities (3 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (1.2k citations), Microbiology (75 citations), Pulmonary and Respiratory Medicine (207 citations) and Molecular Medicine (23 citations). Bisha Ding has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Weiyang Lou, Weimin Fan, Liang Xu, Weimin Fan, Weiyang Lou, Peifen Fu, Jin‐Xing Liu, Guansheng Zhong, Danni Chen and Chang Bao. Their work appears in journals such as Aging, Frontiers in Cell and Developmental Biology, Bioscience Reports, Cell Death and Disease and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.